Charles J Milrod

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Top Venues

Clinical nuclear medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Charles J Milrod, Kang Woo Kim, Christina A Raker, Thomas A Ollila, Adam J Olszewski, Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis. British journal of haematology (2024)
Charles J Milrod, Cory Brown, Anthony E Mega
Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma. Clinical nuclear medicine 49 (7) (2024)
Charles J Milrod, Kang Woo Kim, Christina A Raker, Thomas A Ollila, Adam J Olszewski, Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis. British journal of haematology 204 (6) (2024)
Charles J Milrod, Cory Brown, Anthony E Mega
Increased PSMA-Targeted 18F-DCFPyL Uptake in Peripheral T-Cell Lymphoma. Clinical nuclear medicine (2024)
Charles J Milrod, Cory Brown, Anthony E Mega
Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma. Clinical nuclear medicine 49 (7) (2024)
Charles J Milrod, Kang Woo Kim, Christina A Raker, Thomas A Ollila, Adam J Olszewski, Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis. British journal of haematology 204 (6) (2024)
Charles J Milrod, Frances Blevins, David M Hughes, Adam Lerner, Shayna R Sarosiek, Vaishali Sanchorawala, J Mark Sloan
Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood 137 (21) (2021)